SCHEMBL6501253

SCHEMBL6501253

CCOC(=O)CCCOc1cc(C)c2nc(OCC)n(Cc3ncc(C(F)(F)F)cc3Cl)c2c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
HPGD P15428 1/20 0.39
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 2/20 0.35
PDK2 Q15119 1/20 0.35
GAA P10253 1/20 0.35
MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492273 0.93 MCL1 (0.39) L3MBTL1HPGDMEN1KMT2AALDH1A1
SCHEMBL6489825 0.92 L3MBTL1 (0.43) L3MBTL1HPGDMEN1KMT2AKDM4E
SCHEMBL6497809 0.82 MCL1 (0.41) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL6489292 0.81 MCL1 (0.38) HPGDALDH1A1MAPTGAAMCL1
SCHEMBL6488957 0.81 BCL2 (0.42) L3MBTL1MEN1KMT2ATDP1POLB
SCHEMBL6502360 0.81 PABPC1 (0.39) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL6497506 0.80 PDE3B (0.43) L3MBTL1HPGDMEN1KMT2AKDM4E
SCHEMBL7191530 0.80 AGTR1 (0.40) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL6489607 0.80 MEN1 (0.41) L3MBTL1HPGDMEN1KMT2AKDM4E
SCHEMBL6490102 0.79 LMNA (0.43) L3MBTL1HPGDMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD L3MBTL1 790/4885HPGD 2381/4885MEN1 1604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.